IPCA LABORATORIES
Back to Balance Sheet
|
IPCA LABORATORIES Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹519 Cr | ₹969 Cr | ₹1,014 Cr | ₹902 Cr | ₹614 Cr |
What is the latest Total Non-Current Liabilities ratio of IPCA LABORATORIES ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹519 Cr |
| Mar2025 | ₹969 Cr |
| Mar2024 | ₹1,014 Cr |
| Mar2023 | ₹902 Cr |
| Mar2022 | ₹614 Cr |
How is Total Non-Current Liabilities of IPCA LABORATORIES Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹519 Cr | -46.48 | |
| Mar2025 | ₹969 Cr | -4.46 | |
| Mar2024 | ₹1,014 Cr | 12.50 | |
| Mar2023 | ₹902 Cr | 46.89 | |
| Mar2022 | ₹614 Cr | - | |
Compare Total Non-Current Liabilities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹46,509.6 Cr | -5.4% | -0.2% | 39.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹448,688.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹295,080.0 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹177,677.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹115,852.0 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| CIPLA | ₹111,731.0 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | -5.4% |
-0.2% |
39.1% |
| SENSEX | 1.8% |
11.1% |
-1.6% |
You may also like the below Video Courses